Workflow
贵金属催化剂
icon
Search documents
凯立新材10月9日获融资买入4007.84万元,融资余额1.54亿元
Xin Lang Cai Jing· 2025-10-10 01:23
资料显示,西安凯立新材料股份有限公司位于陕西省西安市经济技术开发区高铁新城尚林路4288号,成 立日期2002年3月15日,上市日期2021年6月9日,公司主营业务涉及主要从事贵金属催化剂的研发与生 产、催化应用技术的研究开发、废旧贵金属催化剂的回收及再加工等业务。主营业务收入构成为:催化 剂销售86.14%,其他(补充)7.16%,催化剂加工6.67%,技术服务费0.03%。 分红方面,凯立新材A股上市后累计派现3.72亿元。近三年,累计派现2.22亿元。 融券方面,凯立新材10月9日融券偿还0.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00元; 融券余量0.00股,融券余额0.00元,超过近一年50%分位水平,处于较高位。 责任编辑:小浪快报 10月9日,凯立新材跌5.09%,成交额1.96亿元。两融数据显示,当日凯立新材获融资买入额4007.84万 元,融资偿还1903.47万元,融资净买入2104.37万元。截至10月9日,凯立新材融资融券余额合计1.54亿 元。 截至6月30日,凯立新材股东户数5848.00,较上期减少2.17%;人均流通股22350股,较上期增加 2.22%。20 ...
博苑股份9月22日获融资买入2382.65万元,融资余额1.13亿元
Xin Lang Cai Jing· 2025-09-23 01:45
9月22日,博苑股份涨1.41%,成交额2.84亿元。两融数据显示,当日博苑股份获融资买入额2382.65万 元,融资偿还3645.92万元,融资净买入-1263.28万元。截至9月22日,博苑股份融资融券余额合计1.13 亿元。 融资方面,博苑股份当日融资买入2382.65万元。当前融资余额1.13亿元,占流通市值的4.39%。 融券方面,博苑股份9月22日融券偿还0.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00元; 融券余量0.00股,融券余额0.00元。 资料显示,山东博苑医药化学股份有限公司位于山东省寿光市侯镇海洋化工园区新海路与大九路路口北 200米,成立日期2008年8月6日,上市日期2024年12月11日,公司主营业务涉及专业从事精细化学品研 发、生产、销售及资源综合利用的高新技术企业,主营业务包括有机碘化物、无机碘化物、贵金属催化 剂、发光材料、六甲基二硅氮烷等产品的研发、生产、销售,并基于资源综合利用资质与工艺技术优势 开展含碘、贵金属等物料的回收利用业务,为客户提供贵金属催化剂、六甲基二硅氮烷等加工服务。主 营业务收入构成为:碘化物74.56%,特种功能化学品12.79% ...
凯立新材(688269):2025 年中报点评:Q2业绩同环比增长,看好长期成长性
Investment Rating - The report maintains a "Buy" rating for the company [2][6]. Core Views - The company experienced both year-on-year and quarter-on-quarter revenue growth in Q2 2025, with expectations for long-term growth potential [2][12]. - The precious metal catalysts are anticipated to perform well across multiple sectors, contributing to the company's growth [12]. Financial Summary - Total revenue for 2023 is projected at 1,785 million, with a decrease of 5.1% from the previous year. However, revenue is expected to grow significantly in the following years, reaching 3,115 million by 2027, reflecting a compound annual growth rate (CAGR) of 19.6% [4][13]. - Net profit attributable to shareholders is forecasted to decline to 113 million in 2023, down 48.9% year-on-year, but is expected to rebound to 351 million by 2027, with a CAGR of 47.4% [4][13]. - Earnings per share (EPS) is expected to increase from 0.86 in 2023 to 2.69 in 2027, indicating strong growth potential [4][13]. - The return on equity (ROE) is projected to improve from 11.4% in 2023 to 24.9% in 2027, showcasing enhanced profitability [4][13]. Market Data - The target price for the company's stock is set at 45.56 yuan, compared to the current price of 36.66 yuan, indicating a potential upside [6][12]. - The company has a market capitalization of 4,792 million, with a 52-week price range of 21.11 to 40.61 yuan [6][12]. Sales Performance - In the first half of 2025, the company achieved a total revenue of 1,014 million, representing a year-on-year increase of 24.86%. The net profit for the same period was 61 million, up 30.83% year-on-year [12]. - The sales volume of catalyst products reached a historical high, with significant growth in various sectors, including pharmaceuticals (49.26%), basic chemicals (185.54%), and environmental new energy (1497.06%) [12]. Product Development - The company is focusing on expanding its presence in the fine chemical sector, particularly in basic chemicals, with several new products launched [12]. - The development of high-performance catalysts and automation in production processes has shown significant progress, enhancing the company's competitive edge [12]. Precious Metal Market Outlook - The report highlights the expected recovery in the prices of precious metals, which are crucial for the company's catalyst production. The prices of palladium and platinum have shown positive trends in Q2 2025 [12].
博苑股份跌2.03%,成交额1.17亿元,主力资金净流出226.47万元
Xin Lang Cai Jing· 2025-09-15 02:09
Core Viewpoint - The stock of Shandong Boyuan Pharmaceutical Chemical Co., Ltd. has shown significant price increases this year, with a year-to-date rise of 108.17% as of September 15, 2023, despite a recent decline in trading [1][2]. Group 1: Company Overview - Shandong Boyuan Pharmaceutical Chemical Co., Ltd. was established on August 6, 2008, and is located in Shouguang City, Shandong Province [2]. - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2]. - The revenue composition of the company includes 74.56% from iodides, 12.79% from specialty functional chemicals, 9.94% from trading, and 2.72% from other sources [2]. Group 2: Financial Performance - For the first half of 2025, the company achieved operating revenue of 747 million yuan, representing a year-on-year growth of 7.39%, while the net profit attributable to shareholders decreased by 19.09% to 99.04 million yuan [2]. - The company has distributed a total of 88.41 million yuan in dividends since its A-share listing [3]. Group 3: Stock Performance and Trading Activity - As of September 15, 2023, the stock price was 80.64 yuan per share, with a market capitalization of 10.777 billion yuan [1]. - The stock has experienced a trading volume of 1.17 billion yuan, with a turnover rate of 4.25% [1]. - The stock has appeared on the "Dragon and Tiger List" four times this year, with the most recent net buy of 51.18 million yuan on September 9, 2023 [1].
博苑股份9月4日获融资买入2775.30万元,融资余额1.18亿元
Xin Lang Cai Jing· 2025-09-05 02:14
Group 1 - The core viewpoint of the news highlights the recent stock performance of Baoyuan Co., which experienced a decline of 5.72% on September 4, with a trading volume of 484 million yuan [1] - On September 4, Baoyuan Co. had a financing buy-in amount of 27.75 million yuan and a financing repayment of 99.64 million yuan, resulting in a net financing outflow of 71.89 million yuan [1] - As of September 4, the total margin balance for Baoyuan Co. was 118 million yuan, accounting for 5.84% of its circulating market value [1] Group 2 - Baoyuan Co. is located in Shouguang City, Shandong Province, and was established on August 6, 2008, with its main business involving the research, production, and sales of fine chemicals [2] - The company's main revenue sources include iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2] - For the first half of 2025, Baoyuan Co. reported a revenue of 747 million yuan, representing a year-on-year growth of 7.39%, while the net profit attributable to shareholders decreased by 19.09% to 99.04 million yuan [2] Group 3 - Baoyuan Co. has cumulatively distributed 88.41 million yuan in dividends since its A-share listing [3]
凯立新材股价微涨0.05% 社保基金二季度增持503万股
Jin Rong Jie· 2025-08-26 18:01
Group 1 - As of August 26, 2025, the stock price of Kaili New Materials is 40.61 yuan, with a slight increase of 0.02 yuan from the previous trading day [1] - The trading volume on that day was 22,982 lots, with a total transaction amount of 94 million yuan, and the intraday price fluctuation was 3.13% [1] - Kaili New Materials is primarily engaged in the research, production, and sales of precious metal catalysts, with applications in pharmaceuticals, chemicals, and environmental protection [1] Group 2 - By the end of the second quarter, two social security funds appeared in the top ten circulating shareholders of the company, holding a total of 5.0314 million shares, which is an increase of 8.83% compared to the end of the first quarter, accounting for 3.85% of circulating shares [1] - The market value of the shares held by social security funds reached 167 million yuan [1] - On August 26, the net inflow of main funds was 9.6065 million yuan, with a cumulative net inflow of 3.9938 million yuan over the past five trading days [1]
博苑股份8月22日获融资买入8520.40万元,融资余额1.52亿元
Xin Lang Cai Jing· 2025-08-25 01:46
Group 1 - On August 22, Boyuan Co., Ltd. saw a stock price increase of 8.61% with a trading volume of 598 million yuan [1] - The financing buy amount for Boyuan Co., Ltd. on the same day was 85.204 million yuan, with a net financing purchase of 36.4176 million yuan [1][2] - As of August 22, the total financing and securities lending balance for Boyuan Co., Ltd. was 152 million yuan, accounting for 9.36% of its circulating market value [2] Group 2 - Boyuan Co., Ltd. is located in Shouguang City, Shandong Province, and was established on August 6, 2008, with its listing date set for December 11, 2024 [2] - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2] - The revenue composition of Boyuan Co., Ltd. includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2] Group 3 - As of August 20, the number of shareholders for Boyuan Co., Ltd. was 13,200, a decrease of 0.14% from the previous period [3] - The average circulating shares per person increased by 0.14% to 2,524 shares [3] - For the first half of 2025, Boyuan Co., Ltd. achieved an operating income of 747 million yuan, a year-on-year increase of 7.39%, while the net profit attributable to shareholders decreased by 19.09% to 99.0429 million yuan [3] Group 4 - Boyuan Co., Ltd. has cumulatively distributed 88.408 million yuan in dividends since its A-share listing [4]
陕西瑞科转战北交所IPO 申报前12个月新增8名股东
Mei Ri Jing Ji Xin Wen· 2025-07-22 12:44
Core Viewpoint - Shaanxi Ruike New Materials Co., Ltd. is pursuing an IPO on the Beijing Stock Exchange, but its revenue has been declining over the past three years [2][3] Group 1: Financial Performance - The company's revenue for the years 2022, 2023, and 2024 was 1.185 billion, 1.152 billion, and 1.052 billion respectively, indicating a downward trend [3] - The net profit attributable to the parent company, after deducting non-recurring gains and losses, was 70.07 million, 60.15 million, and 64.71 million for the same years [3] - Sales to WuXi AppTec, the largest customer, decreased from 192 million in 2022 to 40 million in 2024, with its contribution to overall revenue dropping from 16.23% to 3.77% [4] Group 2: Business Model - The company primarily engages in the research, production, and sales of precious metal catalysts, with applications in various industries including pharmaceuticals, specialty chemicals, and environmental protection [3] - The revenue from processing precious metal catalysts on a commission basis accounted for approximately 10% of total revenue during the reporting period [3] Group 3: Shareholder Structure - Eight new shareholders, including four institutional investors, acquired shares through block trading within 12 months prior to the IPO application [5] - The underwriter, Guosen Securities, indirectly holds 0.73% of the company's shares through two institutional shareholders [6] - Several new shareholders inherited buyback rights from previous shareholders, which raises questions about the compliance of these arrangements with the IPO process [7]
陕西瑞科转战北交所IPO:申报前12个月内新增8名股东 保荐机构间接入股并参与对赌协议
Mei Ri Jing Ji Xin Wen· 2025-07-21 11:56
Core Viewpoint - Shaanxi Ruike New Materials Co., Ltd. is pursuing an IPO on the Beijing Stock Exchange, but its revenue has been declining during the reporting period from 2022 to 2024 [1][3]. Financial Performance - The total revenue for Shaanxi Ruike from 2022 to 2024 is projected to decline from 1.184 billion yuan in 2022 to 1.052 billion yuan in 2024, with net profits decreasing from 111.49 million yuan to 69.03 million yuan [2][3]. - The company's gross profit margin has shown slight improvement, increasing from 11.12% in 2022 to 12.31% in 2024 [2]. Customer Dependency - The company's major client, WuXi AppTec, has seen a significant decrease in its revenue contribution, dropping from 192 million yuan in 2022 to 40 million yuan in 2024, with its share of total revenue falling from 16.23% to 3.77% [4][7]. - Shaanxi Ruike's business model includes sales of precious metal catalysts and processing services, with the processing revenue accounting for approximately 10% of total income during the reporting period [3]. Shareholder Changes - Eight new shareholders, including four institutional investors, acquired shares in Shaanxi Ruike within 12 months prior to the IPO application, primarily through share transfers [1][8]. - The underwriter for the IPO, Guosen Securities, indirectly holds 0.73% of the company's shares through two institutional shareholders, raising questions about compliance with regulations [8][11]. Agreements and Contracts - Previous agreements involving the company's actual controllers included clauses related to share repurchase in the event of IPO failure, which have been inherited by some of the new shareholders [9][10].
【宝鸡】科技创新中的宝鸡突围
Shan Xi Ri Bao· 2025-07-09 23:56
Group 1: Agricultural Innovation - The "Bao Jiao No. 29" chili pepper variety, developed by the Baoji Agricultural Science Research Institute, has a unique aroma and can yield 600 kg of dried peppers per mu [1] - Farmers have reported significant profits from high-quality crops, such as the "Bao Bean 1519" and "Bao Bean No. 10," with one farmer earning 217,000 yuan from 160 mu of soybeans [1] - The research institute is involved in over 30 national and provincial technology research and demonstration projects, focusing on breeding resilient and high-quality crop varieties [2] Group 2: Chemical Industry Development - Shaanxi Ruike New Materials Co., Ltd. is a key player in the domestic fine chemical sector, specializing in the production of precious metal catalysts [2] - The company has developed hundreds of precious metal catalysts for various applications, including pharmaceuticals, pesticides, and food additives [2] - Ruike Materials has 36 invention patents and has participated in the formulation of over 40 national and industry standards, positioning itself as a national-level "specialized and innovative" enterprise [4] Group 3: Sustainability and Innovation - The green recycling and regeneration of precious metal catalysts is crucial due to the scarcity of these metals, enhancing the entire industry chain and promoting low-carbon development [4] - Baoji is committed to agricultural innovation and the cultivation of new high-quality varieties, aiming to establish a solid foundation for modern agricultural development [4] - The city is also focusing on technological innovation and industry clustering to drive high-quality development in the new materials sector [4]